Mylan Laboratories was founded in 1961, its mission was to help make quality medicines more affordable for patients who need them. Mylan is committed to become the premier U.S. generic pharmaceutical company. Mylan aim to increase prescription volume, increase market share and improve margins by decreasing expenses. Mylan Laboratories' subsidiaries are all US based and are as follows: Mylan Pharmaceuticals, Milan Holding, Bertek Pharmaceuticals, Mylan, UDL Laboratories, Mylan Technologies, American Triumvirate Insurance Company, Mylan International Holdings, and Mylan Caribe. Bertek is a transitional pharmaceutical company that will enable Mylan to grow from a traditional generic company to a proprietary based company.